Insights On Upstream Manufacturing
-
Nucleus Biologics Bio-Expo Live 2024: Upstream Bioprocessing
8/15/2024
Discover how Nucleus Biologics can expedite all stages of development from design and optimization, process development scale-up and GMP readiness, and commercial-scale manufacturing.
-
Mirus Bio Bio-Expo Live 2024: Upstream Bioprocessing
8/14/2024
Explore a proprietary economic model which quantitates the impact of upstream process optimization with varying transfection technologies using real world case studies.
-
MilliporeSigma Bio-Expo Live 2024: Upstream Bioprocessing
8/14/2024
Learn about a 2 mL automated, single-use perfusion microbioreactor that enables running simultaneous and controlled experiments for cell line development, media screening and optimization, and early process development.
-
Helix Biotech Bio-Expo Live 2024: Upstream Bioprocessing
8/14/2024
Watch a virtual demonstration of the Nova Benchtop IJM system, a flexible, modular platform that simplifies the production of lipid nanoparticles, liposomes, and hybrid nanoparticles.
-
Federal Equipment Company Bio-Expo Live 2024: Upstream Bioprocessing
8/14/2024
Federal Equipment Company is a reliable resource for all bioprocessing biotechnology equipment needs, with over 60 years of expertise buying and selling used equipment.
-
Culture Biosciences Bio-Expo Live 2024: Upstream Bioprocessing
8/14/2024
Culture Biosciences solutions enable real-time data transparency and innovative modeling techniques that accelerate cell culture process development, optimize bioprocess outcomes, and drive the digital transformation of the industry.
-
Navigating 5 Overlooked Challenges In Bioconjugate Manufacturing
8/14/2024
Delve into the intricacies of ADC production and learn how cutting-edge technologies are being deployed to overcome these hurdles to bring life-saving treatments to patients.
-
Boosting Cell Culture Yields With Intensified Fed Batch Processing
8/12/2024
Traditional fed-batch cell culture processes face limitations due to inherent cell line restrictions and accumulation of byproducts during the process, necessitating new approaches that improve cell performance.
-
Enabling Rapid Stable Cell Line Development For Enhanced HIV Vaccine Efficacy
8/8/2024
Explore the advancements being made in HIV vaccine development using MaxCyte STX electroporation technology. Explore the engineering of a CHO cell line to express the HIV envelope glycoprotein rgp120.
-
The Fast Track To IND
8/5/2024
Explore automated cell line development service and media with a proven success record across various CHO-based protein expression systems, including IgG1, IgG2, IgG4, Fc-Fusion, Bi-Specifics, and more.